You're viewing a free preview.You're viewing a free preview — a sample of each dataset.

News Feed

Daily longevity science headlines — aging research, deals, trials, and policy — with AI summaries.

532 news items tracked

Headline	Source	Category	Published
GlobalData forecasts Alzheimer's drug market across eight major markets will grow from $2.4B in 2023 to $14.7B by 2033	GlobalData	Industry	10/14/26
Cognition Therapeutics gets US composition-of-matter patent for zervimesine (CT1812) through 2045	GlobeNewswire	Industry	10/13/26
iBio reports primate data for IBIO-610, an Activin E antibody, with semaglutide	GlobeNewswire	Research	10/13/26
Function Health and Google Health link lab results with wearable data	PR Newswire	Industry	10/12/26
Abu Dhabi Public Health Centre and Ultrahuman to build a biological health age model	Abu Dhabi Media Office	Industry	10/12/26
Immorta Bio describes AI-designed senolytic peptide SenoMune-0257 ahead of planned human evaluation	PR Newswire	Research	10/12/26
Sava raises $36M Series B and signs European deal with Ascensia for its glucose microsensor wearable	Sava	Funding	10/09/26
Life Biosciences reports first-in-human data for ER-100, a partial epigenetic reprogramming therapy, in glaucoma	GlobeNewswire	Clinical	10/08/26
Restore Hyper Wellness and Niagen Bioscience launch an October "Longevity Month" promotion	PR Newswire	Industry	10/08/26
Singapore launches S$25M Healthy Longevity Institute and a brain-health partnership with the International Alliance on Brain Health	USI	Funding	10/08/26

Showing 10 of 532 news items

Peek at other modules

The longevity science company universe by segment, stage, geography and capital raised.

Every disclosed longevity science round — size, stage and the investors behind it.

Longevity science and aging research trials by phase, sponsor, status and indication.

Who is joining, leaving and founding across longevity science and aging research.

Peer-reviewed aging research distilled into investor-relevant takeaways.

FDA, EMA and policy developments that move aging research and the longevity market.